IL195922A0 - Adverse drug reaction reduction - Google Patents
Adverse drug reaction reductionInfo
- Publication number
- IL195922A0 IL195922A0 IL195922A IL19592208A IL195922A0 IL 195922 A0 IL195922 A0 IL 195922A0 IL 195922 A IL195922 A IL 195922A IL 19592208 A IL19592208 A IL 19592208A IL 195922 A0 IL195922 A0 IL 195922A0
- Authority
- IL
- Israel
- Prior art keywords
- adverse drug
- drug reaction
- reaction reduction
- reduction
- adverse
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL195922A IL195922A (en) | 2006-06-22 | 2008-12-14 | Method for adverse drug reaction reduction |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81599906P | 2006-06-22 | 2006-06-22 | |
PCT/IL2007/000754 WO2007148340A2 (en) | 2006-06-22 | 2007-06-21 | Adverse drug reaction reduction |
IL195922A IL195922A (en) | 2006-06-22 | 2008-12-14 | Method for adverse drug reaction reduction |
Publications (2)
Publication Number | Publication Date |
---|---|
IL195922A0 true IL195922A0 (en) | 2009-09-01 |
IL195922A IL195922A (en) | 2013-11-28 |
Family
ID=42110897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL195922A IL195922A (en) | 2006-06-22 | 2008-12-14 | Method for adverse drug reaction reduction |
Country Status (1)
Country | Link |
---|---|
IL (1) | IL195922A (en) |
-
2008
- 2008-12-14 IL IL195922A patent/IL195922A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
IL195922A (en) | 2013-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1127356A1 (en) | Pharmaceutical compounds | |
GB0608820D0 (en) | Pharmaceutical compounds | |
EP2038836A4 (en) | Adverse drug reaction reduction | |
EP1992348A4 (en) | Pharmaceutical combination | |
GB0603501D0 (en) | Catalyst | |
GB0614909D0 (en) | Catalyst | |
GB0603041D0 (en) | Therapeutic compounds | |
ZA200809479B (en) | New pharmaceutical compounds | |
EP2035369A4 (en) | Therapeutic compounds | |
ZA200806318B (en) | Drug combinations | |
GB0625783D0 (en) | Medicament | |
IL197883A0 (en) | Combination drug | |
EP2079704A4 (en) | Therapeutic compounds | |
GB0608184D0 (en) | Pharmaceutical compounds | |
GB0608176D0 (en) | Pharmaceutical Compounds | |
GB0615064D0 (en) | Medicament | |
GB0613031D0 (en) | Medicaments | |
GB0603455D0 (en) | Therapeutic compounds | |
ZA200901142B (en) | Reaction system | |
GB0608264D0 (en) | Pharmaceutical compounds | |
GB0608175D0 (en) | Pharmaceutical Compounds | |
GB0625682D0 (en) | Pharmaceutical compounds | |
GB0622892D0 (en) | Pharmaceutical compounds | |
GB0615814D0 (en) | Medicament | |
IL195922A0 (en) | Adverse drug reaction reduction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |